By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mologen AG 

P.O. Box 332140

Berlin    D - 14180  Germany
Phone: 49-0-30-857-576-0 Fax: 49-0-30-857-576-50



Gene Therapy

Company News
Mologen AG (MOLGF.PK): Cancer Immune Therapy MGN1703 Shows Outstanding Long-Term Responses 6/30/2014 9:30:39 AM
Mologen AG (MOLGF.PK) To Present Two Posters At ESMO WCGI 2014 6/12/2014 8:02:47 AM
Mologen AG (MOLGF.PK): Development Of Main Product Candidate Pushed Forward Swiftly In First Quarter 5/14/2014 9:33:00 AM
Mologen AG (MOLGF.PK): DSLIMĀ® Shows Superior Immunoactivation Capabilities 4/8/2014 2:01:28 PM
Mologen AG (MOLGF.PK): Change Within the Supervisory Board - Chairman Resigns Due to Health Reasons as Announced - Successor Nominated 7/1/2013 7:19:02 AM
Mologen AG (MOLGF.PK) Expands Its Executive Board by Chief Medical Officer 3/26/2013 12:08:42 PM
Mologen AG (MOLGF.PK): Research and Financing Successes in the 2012 Financial Year 3/21/2013 12:31:30 PM
Mologen AG (MOLGF.PK): Promising Start to 2012 Business Year - Quarterly Report Submitted 5/15/2012 11:42:03 AM
Mologen AG (MOLGF.PK) -- Excellent Outcome for Phase 2 Colorectal Cancer Study With MGN1703 -- Primary Endpoint Achieved 5/14/2012 10:39:16 AM
Mologen AG (MOLGF.PK) Attains the Goals of the Renal Cancer Study With MGN1601 Ahead of Schedule 11/21/2011 10:21:28 AM